Primus In News
Indian pharma ramps up US acquisitions amid regulatory and market shifts
15-03-2025
Nilaya Varma, CEO & Co-Founder, Primus Partners, and Vivek Tandon, Vice President, Primus Partners, share their view on the expansion of Indian pharmaceutical companies in the US through strategic acquisitions. They highlight Sun Pharma’s $355 million acquisition of Checkpoint Therapeutics as a key move to bolster its oncology and immunotherapy portfolio.
Explore Related Insights
- Crypto Start-Ups Look Beyond Exchanges Amid Regulatory Turbulence
- Union Budget 2025 Expectations Live Updates: What are industries expecting from FM Nirmala Sitharaman?
- Electric bus makers gear up for Delhiās full fleet electrification
- Digital Learning Helps Save 2020 From Becoming A Void Year For Students But Challenges Remain: Reports